Catheter Precision announced that VIVO was used in five procedures for the first time in Qatar at Hamad Medical Corporation Heart Hospital in Doha. Hamad Medical Corporation is the main provider of secondary and tertiary healthcare in Qatar and one of the leading hospital providers in the Middle East. HMC manages 12 hospitals – nine specialist hospitals and three community hospitals.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on VTAK:
- Catheter Precision announces first use of LockeT outside of U.S.
- Catheter Precision announces first use of VIVO with pediatric patient
- Catheter Precision Converts Preferred Stock to Common Shares
- Catheter Precision enters distribution agreement in Turkey
- Catheter Precision enters distribution agreement with SUPRI